Small Research Grant Program for the Next Generation of Researchers in Low- and Middle-Income Countries for Aging and AD and ADRD Research (R03 Clinical Trial Not Allowed) (RFA-AG-25-031)

Sponsor: National Institute on Aging

Award: Application budgets are limited to $100,000 in direct cost per year. The project period is limited to 2 years.

Due Date: Letter of Intent due October 7, 2024. Application due November 07, 2024 or February 14, 2025.

Notice of Special Interest (NOSI): Administrative Supplement Program to Add Fluid-based Biomarkers and APOE Genotyping to NINDS ADRD Human Subjects Research Grants (NOT-NS-24-109)

Sponsor: National Institute of Neurological Disorders and Stroke, National Institute on Aging

Award: One-year administrative supplement to provide support for currently active NINDS Alzheimer’s Disease and Alzheimer’s Disease Related Dementias (AD/ADRD) awards to add/include APOE genotype and fluid-based AD/ADRD biomarkers to ongoing AD/ADRD human subjects research studies. Individual requests can be no more than $150,000 in direct costs.

Due Date: November 11, 2024.

ADRD Risk and Disease Following Nervous System Exposures at Biological Interfaces with the Environment (R01 - Clinical Trial Not Allowed) (PAR-24-270)

Sponsor: National Institute of Neurological Disorders and Stroke, National Institute on Aging

Due Date: November 19, 2024.

Notice of Intent to Publish an FOA for NIA Advanced Postdoctoral Career Transition Awards to Promote Diversity in Translational Research for AD/ADRD (K99/R00 Clinical Trial Not Allowed)(NOT-AG-24-060)

Sponsor: National Institute on Aging

Due Date: Estimated Publication Date of Notice of Funding Opportunity: November 01, 2024. First Estimated Application Due Date: February 12, 2025.

Clinical Trials Addressing Unmet Needs of Rare Neurodegenerative Diseases (R01) Clinical Trials Required (RFA-FD-25-001)

Sponsor: U.S. Food and Drug Administration

Due Date: 2024 dates: LOI due September 22, 2024; application due October 22, 2024. 2025 dates: LOI due September 21, 2025; application due October 21, 2025.

Optimization of Genome Editing Therapeutics for Alzheimer's Disease-Related Dementias (ADRD) (U01 - Clinical Trials Not Allowed) (RFA-NS-24-037)

Sponsor: National Institute of Neurological Disorders and Stroke, National Institute on Aging

Award: Application budgets are limited to no more than $1,000,000 in direct costs per year. The maximum project period is five years.

Due Date: November 19, 2024.

Notice of Intent to Publish a FOA for Blueprint Neurotherapeutics Network: Biologic-based Drug Discovery and Development for Nervous System Disorders (UG3/UH3 Clinical Trial Optional) (NOT-NS-24-014)

Sponsor: National Institutes of Health

Due Date: Estimated Publication Date of Notice of Funding Opportunity: October 01, 2024. First Estimated Application Due Date: January 27, 2025.

Notice of Intent to Publish a FOA for Blueprint Neurotherapeutics Network: Biologic-based Drug Discovery and Development for Nervous System Disorders (U44 Clinical Trial Optional) (NOT-NS-24-015)

Sponsor: National Institutes of Health

Due Date: Estimated Publication Date of Notice of Funding Opportunity: October 01, 2024. First Estimated Application Due Date: January 27, 2025.

McKnight Scholar Awards

Sponsor: The McKnight Endowment Fund for Neuroscience

Award: Applicants for the McKnight Scholar Awards must be independent investigators at not-for-profit research institutions in the United States and must hold a faculty position at the rank of Assistant Professor and must have served at that rank for less than five years at the application deadline. Each Scholar will receive $75,000 annually in 2025, 2026, and 2027. Funds may be used in any way that will facilitate development of the Scholar’s research program, but not for indirect costs.

Due Date: January 13, 2025 at 5 PM Central Time.

Notice of Termination of RFA-NS-24-028: BRAIN Initiative Connectivity across Scales Data Coordinating Center (BRAIN CONNECTS DCC) (U24 Clinical Trial Not Allowed) (NOT-NS-24-127)

Sponsor: National Institute of Neurological Disorders and Stroke

Due Date: This Notice informs the extramural community that RFA-NS-24-028 “BRAIN Initiative Connectivity across Scales Data Coordinating Center (BRAIN CONNECTS DCC) (U24 Clinical Trial Not Allowed)" will be terminated. The final receipt date, August 21, 2024, has been canceled.

Notice of Intent to Publish a Funding Opportunity Announcement for Promoting Equity Through BRAIN Technology Partnerships (R34 - Clinical Trials Not Allowed) (NOT-NS-24-104)

Sponsor: National Institute of Neurological Disorders and Stroke

Due Date: Estimated Publication Date of Notice of Funding Opportunity: October 01, 2024. First Estimated Application Due Date: February 14, 2025.

Modern Equipment for Shared-use Biomedical Research Facilities: Advancing Research-Related Operations (S15 Clinical Trial Not Allowed) (PAR-24-259)

Sponsor: National Institute of General Medical Sciences

Due Date: Multiple due dates. See announcement.

Notice of Intent to Publish a Funding Opportunity Announcement for Morris K. Udall Discovery Centers without Walls (DCWoW) for Parkinson's Disease Research (RM1 - Clinical Trial Optional) (NOT-NS-24-0

Sponsor: National Institute of Neurological Disorders and Stroke

Due Date: Estimated Publication Date of Notice of Funding Opportunity: November 01, 2024. First Estimated Application Due Date: March 14, 2025.

Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Not Allowed)(PAR-24-225)

Sponsor: National Institutes of Health

Due Date: Multiple due dates; see announcement.

Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00 - Independent Clinical Trial Required) (PAR-24-226)

Sponsor: National Institutes of Health

Due Date: Multiple due dates; see announcement.